GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,334,000 | +20.7% | 30,654 | +20.9% | 0.07% | +37.5% |
| Q1 2022 | $1,105,000 | -1.2% | 25,364 | +0.0% | 0.05% | +6.7% |
| Q4 2021 | $1,118,000 | +15.3% | 25,359 | -0.1% | 0.04% | +7.1% |
| Q3 2021 | $970,000 | -96.8% | 25,389 | -96.7% | 0.04% | -96.8% |
| Q2 2021 | $30,638,000 | +13.5% | 769,419 | +1.7% | 1.32% | -22.7% |
| Q1 2021 | $26,999,000 | +9.9% | 756,478 | +13.4% | 1.70% | -0.6% |
| Q4 2020 | $24,556,000 | -0.3% | 667,284 | +2.0% | 1.71% | -26.8% |
| Q3 2020 | $24,626,000 | -3.7% | 654,252 | +4.3% | 2.34% | -14.2% |
| Q2 2020 | $25,585,000 | +15.8% | 627,244 | +7.6% | 2.73% | -12.4% |
| Q1 2020 | $22,095,000 | +5111.1% | 583,147 | +5483.0% | 3.12% | +5779.2% |
| Q3 2017 | $424,000 | -5.8% | 10,445 | 0.0% | 0.05% | -10.2% |
| Q2 2017 | $450,000 | +2.3% | 10,445 | 0.0% | 0.06% | -1.7% |
| Q1 2017 | $440,000 | -11.1% | 10,445 | -18.8% | 0.06% | -16.7% |
| Q4 2016 | $495,000 | -10.8% | 12,865 | 0.0% | 0.07% | +140.0% |
| Q3 2016 | $555,000 | -9.6% | 12,865 | -9.2% | 0.03% | -14.3% |
| Q2 2016 | $614,000 | -87.3% | 14,165 | -88.1% | 0.04% | -87.2% |
| Q1 2016 | $4,821,000 | -5.2% | 118,884 | -5.7% | 0.27% | -4.5% |
| Q4 2015 | $5,086,000 | -7.3% | 126,059 | -11.7% | 0.29% | -14.6% |
| Q3 2015 | $5,486,000 | -10.4% | 142,689 | -3.0% | 0.34% | +3.1% |
| Q2 2015 | $6,126,000 | -13.0% | 147,093 | -3.6% | 0.32% | -13.6% |
| Q1 2015 | $7,040,000 | +7.1% | 152,553 | -0.8% | 0.38% | +2.2% |
| Q4 2014 | $6,572,000 | -6.1% | 153,763 | +1.0% | 0.37% | -5.6% |
| Q3 2014 | $6,996,000 | -9.7% | 152,178 | +5.0% | 0.39% | -7.8% |
| Q2 2014 | $7,749,000 | -1.1% | 144,893 | -1.2% | 0.42% | -4.5% |
| Q1 2014 | $7,832,000 | -5.4% | 146,593 | -5.5% | 0.44% | -4.1% |
| Q4 2013 | $8,281,000 | +27.4% | 155,103 | +19.7% | 0.46% | +23.2% |
| Q3 2013 | $6,501,000 | -3.3% | 129,588 | -3.7% | 0.38% | -10.3% |
| Q2 2013 | $6,721,000 | – | 134,510 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |